These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33461831)

  • 1. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Momoh J; Oteri AJ; Mogekwu F; Onwu N; Dieng B; Bawa S; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C12-C20. PubMed ID: 33714654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Terna Richard M; Taiwo L; Jean Baptiste AE; Bawa S; Dieng B; Wiwa O; Lambo K; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C21-C28. PubMed ID: 34247903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt.
    Hamisu M; Dieng B; Taiwo L; Jean Baptiste AE; Bawa S; Wagai J; Ibizugbe S; Braka F; Nsubuga P; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C46-C53. PubMed ID: 33892983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
    Korave J; Bawa S; Ageda B; Ucho A; Bem-Bura DM; Onimisi A; Dieng B; Nsubuga P; Oteri J; Fiona B; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C76-C81. PubMed ID: 33461836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
    Utazi CE; Wagai J; Pannell O; Cutts FT; Rhoda DA; Ferrari MJ; Dieng B; Oteri J; Danovaro-Holliday MC; Adeniran A; Tatem AJ
    Vaccine; 2020 Mar; 38(14):3062-3071. PubMed ID: 32122718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
    Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R
    Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    Wagai JN; Rhoda D; Prier M; Trimmer MK; Clary CB; Oteri J; Okposen B; Adeniran A; Danovaro-Holliday C; Cutts F
    PLoS One; 2021; 16(2):e0247415. PubMed ID: 33635913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009.
    Pezzoli L; Conteh I; Kamara W; Gacic-Dobo M; Ronveaux O; Perea WA; Lewis RF
    BMC Public Health; 2012 Jun; 12():415. PubMed ID: 22676225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
    Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
    Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019.
    Jean Baptiste AE; Wagai J; Luce R; Masresha B; Klinkenberg D; Veldhuijzen I; Oteri J; Dieng B; Ikeonu OC; Meleh S; Musa A; Braka F; Hahné S; Sanders EAM; Hak E
    BMC Public Health; 2021 Mar; 21(1):437. PubMed ID: 33663439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
    Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
    Elife; 2021 Jun; 10():. PubMed ID: 34165077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of WhatsApp group messaging in the coordination of measles supplemental immunization activity in Cross Rivers State, Nigeria, 2018.
    Masresha B; Nwankwo O; Bawa S; Igbu T; Oteri J; Tafida H; Braka F
    Pan Afr Med J; 2020; 35(Suppl 1):6. PubMed ID: 32373257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.